GT Bio
1 known investors
GT Bio develops an in vivo drug delivery atlas that combines drug delivery, targeted conjugates, spatial biology, and machine learning to enable cell type-specific delivery for precision medicine. The company generates in vivo delivery data intended to support the development of next-generation drug delivery systems for patients.
Founders & leadership
Investors · 1
Frequently asked questions
- What does GT Bio do?
- GT Bio develops an in vivo drug delivery atlas that combines drug delivery, targeted conjugates, spatial biology, and machine learning to enable cell type-specific delivery for precision medicine. The company generates in vivo delivery data intended to support the development of next-generation drug delivery systems for patients.
- Who founded GT Bio?
- GT Bio was founded by Tay Shin, Chi Zhang.
- Who are GT Bio's investors?
- GT Bio's investors include Fifty Years.